Incidentaloma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Usama Talib (talk | contribs) Created page with "__NOTOC__ {{Incidentaloma}} {{CMG}}; {{AE}} ==Overview== There are no established measures for the secondary prevention of [disease name]. OR Effective measures for the se..." |
No edit summary |
||
| Line 11: | Line 11: | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
*Effective measures for the secondary prevention of [disease name] include: | *Effective measures for the secondary prevention of [disease name] include: | ||
** | *Excess hormone secretion may develop in up to 20% of patients with previously nonfunctional adrenal tumors during follow- up (37, 38, 123). | ||
** | *The transformation rate of nonfunctional adrenal masses to functional tumors seems to be higher in adrenal masses greater than 3 cm in size (38). | ||
** | |||
* Annual biochemical follow-up for up to 5 yr may be reasonable for patients with adrenal incidentalomas, especially if the tumor is more than 3 cmin size (20, 21, 37, 45). | |||
* No routine follow-up of adrenal incidentalomas with a non-contrast attenuation value no greater than 10 HU. | |||
*A one-time follow-up scan in 6–12 months may be reassuring to the physician and the patient (2, 12, 40, 124). | |||
* Patients with adrenal masses less than 4 cm in size and a non-contrast attenuation value more than 10 HU should have a repeat CT study in 3–6 months and then yearly for 2 yr. | |||
* Surgical excision may be considered for tumors with indeterminate radiological features that grow at least 0.8 cm over 3- to 12-month follow-up (10). | |||
==References== | ==References== | ||
Revision as of 23:54, 29 August 2017
|
Incidentaloma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Incidentaloma secondary prevention On the Web |
|
American Roentgen Ray Society Images of Incidentaloma secondary prevention |
|
Risk calculators and risk factors for Incidentaloma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There are no established measures for the secondary prevention of [disease name].
OR
Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].
Secondary Prevention
- Effective measures for the secondary prevention of [disease name] include:
- Excess hormone secretion may develop in up to 20% of patients with previously nonfunctional adrenal tumors during follow- up (37, 38, 123).
- The transformation rate of nonfunctional adrenal masses to functional tumors seems to be higher in adrenal masses greater than 3 cm in size (38).
- Annual biochemical follow-up for up to 5 yr may be reasonable for patients with adrenal incidentalomas, especially if the tumor is more than 3 cmin size (20, 21, 37, 45).
- No routine follow-up of adrenal incidentalomas with a non-contrast attenuation value no greater than 10 HU.
- A one-time follow-up scan in 6–12 months may be reassuring to the physician and the patient (2, 12, 40, 124).
- Patients with adrenal masses less than 4 cm in size and a non-contrast attenuation value more than 10 HU should have a repeat CT study in 3–6 months and then yearly for 2 yr.
- Surgical excision may be considered for tumors with indeterminate radiological features that grow at least 0.8 cm over 3- to 12-month follow-up (10).